News summary produced by Claude AI
Researchers from University College London, ZSL, and Imperial College London have identified a key factor determining whether amphibian populations survive infection from the chytrid fungus Batrachochytrium dendrobatidis (Bd), which causes chytridiomycosis. The findings were published in the journal Nature Chemical Biology.
The chytrid fungus has caused severe declines in amphibian populations worldwide by damaging the skin of frogs and toads and disrupting their ability to regulate water, salts, and minerals. Young amphibians remain relatively protected during their tadpole stage because larvae lack the keratin-rich skin that the fungus feeds on. Once they metamorphose into adults and develop keratinized skin, they become susceptible to infection, often resulting in mass mortality events.
To understand why some populations recover while others continue declining, the research team studied common midwife toads at four lakes in the Pyrenees of France and Spain that had all experienced severe Bd outbreaks. While one population remained in decline, the other three had rebounded despite the fungus remaining present in their environment. The critical difference involved antimicrobial peptides—natural chemical defenses produced by amphibian skin. Toads from recovering populations developed these protective peptides much earlier during their tadpole stage, establishing immune defenses before becoming vulnerable as adults. In contrast, toads from the declining population produced fewer of these peptides during development, leaving them unprepared once they matured.
Using mass spectrometry to analyze the peptides released from amphibian skin, researchers identified 1,152 distinct peptides, with only seven previously documented. Tadpoles producing a wider variety of peptides during development showed significantly higher survival rates despite ongoing fungal outbreaks. The study suggests that factors such as genetics, temperature, or the presence of predators like trout may influence whether immune systems develop early.
The research team indicated that these newly discovered peptides represent potential leads for developing human medicines, particularly as antimicrobial resistance becomes an increasing concern in medical treatment.